Ophthalmology Contract Research Organization Market Report, 2032

Ophthalmology Contract Research Organization (CRO) Market Size - Service Type (Clinical Research Services {Phase I, Phase II}), Therapy (Traditional, Advanced), End-use, Global Forecast, 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition &amp; scope

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global ophthalmology contract research organization (CRO) industry 3600 synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Service type trends

2.1.4&nbsp;&nbsp;&nbsp; Therapy trends

2.1.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Ophthalmology Contract Research Organization (CRO) Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 - 2032 (USD Million)

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Rising prevalence of eye disorders

3.3.1.2&nbsp;&nbsp;&nbsp;Increasing outsourcing for ophthalmology R&amp;D activities

3.3.1.3&nbsp;&nbsp;&nbsp;Increasing demand for novel ophthalmic therapies

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Varying regulatory requirements across regions

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By service type

3.4.2&nbsp;&nbsp;&nbsp; By therapy

3.4.3&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Ophthalmology clinical trial analysis

3.6.1&nbsp;&nbsp;&nbsp; Ophthalmology clinical trial volume, by region, 2018 - 2022

3.6.2&nbsp;&nbsp;&nbsp; Ophthalmology clinical trial volume, by indication, 2018 - 2022

3.6.3&nbsp;&nbsp;&nbsp; Ophthalmology clinical trial volume, by phase of development, 2018 - 2022

3.7&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7.1&nbsp;&nbsp;&nbsp; U.S.

3.7.2&nbsp;&nbsp;&nbsp; Europe

3.8&nbsp;&nbsp;&nbsp; Drug discovery and development process

3.9&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company positioning matrix

4.4&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Ophthalmology Contract Research Organization (CRO) Market, By Service Type, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by service type

5.2&nbsp;&nbsp;&nbsp; Early phase development services

5.3&nbsp;&nbsp;&nbsp; Clinical research

5.3.1&nbsp;&nbsp;&nbsp; Phase I

5.3.2&nbsp;&nbsp;&nbsp; Phase II

5.3.3&nbsp;&nbsp;&nbsp; Phase III

5.3.4&nbsp;&nbsp;&nbsp; Phase IV

5.4&nbsp;&nbsp;&nbsp; Laboratory services

5.5&nbsp;&nbsp;&nbsp; Regulatory consulting services

Chapter 6&nbsp;&nbsp;&nbsp;Ophthalmology Contract Research Organization (CRO) Market, By Therapy, 2018 &ndash; 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by therapy

6.2&nbsp;&nbsp;&nbsp; Traditional interventions

6.2.1&nbsp;&nbsp;&nbsp; Anti-inflammatory interventions

6.2.1.1&nbsp;&nbsp;&nbsp;Corticosteroids

6.2.1.2&nbsp;&nbsp;&nbsp;NSAIDs

6.2.1.3&nbsp;&nbsp;&nbsp;Immunomodulators

6.2.1.4&nbsp;&nbsp;&nbsp;Other anti-inflammatory interventions

6.2.2&nbsp;&nbsp;&nbsp; Anti-oxidative interventions

6.2.3&nbsp;&nbsp;&nbsp; Other traditional interventions

6.3&nbsp;&nbsp;&nbsp; Advanced interventions

6.3.1&nbsp;&nbsp;&nbsp; Cell therapy

6.3.2&nbsp;&nbsp;&nbsp; Gene theray

6.3.3&nbsp;&nbsp;&nbsp; Other advanced interventions

Chapter 7&nbsp;&nbsp;&nbsp;Ophthalmology Contract Research Organization (CRO) Market, By End-user, 2018 &ndash; 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-user

7.2&nbsp;&nbsp;&nbsp; Pharma/biopharma companies

7.3&nbsp;&nbsp;&nbsp; Medical device companies

7.4&nbsp;&nbsp;&nbsp; Academic institutes

Chapter 8&nbsp;&nbsp;&nbsp;Ophthalmology Contract Research Organization (CRO) Market, By Region, 2018 &ndash; 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; MEA

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Charles River Laboratories International, Inc.

9.2&nbsp;&nbsp;&nbsp; ICON plc

9.3&nbsp;&nbsp;&nbsp; Laboratory Corporation of America Holdings (Covance Inc.)

9.4&nbsp;&nbsp;&nbsp; Medpace, Inc.

9.5&nbsp;&nbsp;&nbsp; Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)

9.6&nbsp;&nbsp;&nbsp; Syneos Health

9.7&nbsp;&nbsp;&nbsp; Worldwide Clinical Trials

9.8&nbsp;&nbsp;&nbsp; WuXi AppTec

9.9&nbsp;&nbsp;&nbsp; ORA Inc.

9.10&nbsp;&nbsp;&nbsp; CTRG (Clinical Trial Resource Group)

9.11&nbsp;&nbsp;&nbsp; Iris Pharma

9.12&nbsp;&nbsp;&nbsp; Trial Runners

9.13&nbsp;&nbsp;&nbsp; The Emmes Company, LLC

9.14&nbsp;&nbsp;&nbsp; Lexitas Pharma Services, Inc.

9.15&nbsp;&nbsp;&nbsp; ProTrial Research, Inc.

9.16&nbsp;&nbsp;&nbsp; TFS HealthScience 
&nbsp;

Ophthalmology Contract Research Organization CRO Market

Get a free sample of this report